EarningsQ4 2023 Earnings Report

Tandem Diabetes Care (TNDM) Q4 2023 Earnings Report

0 Followers

MX:TNDM Q4 2023 EPS Results

Actual EPS-$8.46

Consensus EPS-$4.86

Beat/MissMissed by -$3.60

One Year Ago EPS-$4.60

Actual Revenue$3.62B

Expected Revenue$3.74B

Beat/MissMissed by -$123.18M

YoY Revenue Growth-10.75%

QuarterQ4 2023

Date02/21/2024

TimeAfter Close

Conference CallWednesday, February 21, 2024

MX:TNDM Upcoming Earnings

Tandem Diabetes Care's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:TNDM Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.51 / -	-5.756	―
Aug 06, 2026	2026 (Q2)	-5.90 / -5.65	-8.865	36.31% (+3.22)
May 07, 2026	2026 (Q1)	-8.17 / -5.48	-12.304	55.46% (+6.82)
Feb 19, 2026	2025 (Q4)	-1.71 / -0.17	0.184	-190.00% (-0.35)
Nov 06, 2025	2025 (Q3)	-6.05 / -5.76	-6.437	10.57% (+0.68)
Aug 06, 2025	2025 (Q2)	-7.34 / -8.86	-8.644	-2.55% (-0.22)
Apr 30, 2025	2025 (Q1)	-11.13 / -12.30	-11.954	-2.92% (-0.35)
Feb 26, 2025	2024 (Q4)	-3.75 / 0.18	-8.46	102.17% (+8.64)
Nov 06, 2024	2024 (Q3)	-7.41 / -6.44	-9.379	31.37% (+2.94)
Aug 01, 2024	2024 (Q2)	-9.84 / -8.64	-10.115	14.55% (+1.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed